Cite

HARVARD Citation

    Pena, M. et al. (2017). The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy. Diabetes, obesity & metabolism. 19 (5), pp. 749-753. [Online]. 
  
Back to record